Background Severe health anxiety is a highly distressing, often debilitating, psychological problem. Since the release of the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5) its clinical manifestations are increasingly often referred to as Somatic Symptom Disorder (SSD) or Illness Anxiety Disorder (IAD). Despite often being overlooked in routine care, several treatments for severe health anxiety have shown great promise, the most well-established being Cognitive Behavioral Therapy (CBT). Traditionally, CBT - like most other psychotherapies - has typically been delivered face-to-face. That is, the patient physically meeting with the therapist once a week for the whole of the treatment. Internet-delivered CBT does not rest on this requirement, but has nevertheless been shown to be efficacious for severe health anxiety (see for example NCT01673035). Aim of the study The present study aims to compare the effects of Internet-delivered CBT and CBT face-to-face for severe health anxiety in a randomized controlled trial. A non-inferiority criterion is applied to determine if Internet-delivered CBT is at least as efficacious as its well-established predecessor.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
204
This intervention entails different exercises aimed at exposure to health anxiety stimuli. Treatment is delivered in a conventional manner. Participants are physically meeting with a therapist once a week.
This intervention entails different exercises aimed at exposure to health anxiety stimuli. Treatment is delivered via the Internet. Participants are guided by a therapist using an email-like communication system.
Gustavsberg primary care clinic
Gustavsberg, Stockholm County, Sweden
Health Anxiety Inventory (HAI)
Change in HAI at post-treatment and follow-ups compared to baseline. Analyses will be conducted both within an intention-to-treat (ITT) framework and on a complete case basis. A non-inferiority limit of 0.3 d (effect size) will be used.
Time frame: baseline, post-treatment (12 weeks), weekly during treatment, 6 month follow-up, 12 month follow-up
Illness Attitude Scale (IAS)
Change in IAS at post-treatment and follow-ups compared to baseline
Time frame: baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Whiteley Index (WI)
Change in WI at post-treatment and follow-ups compared to baseline
Time frame: baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Montgomery-Åsberg Depression Rating Scale - Self report (MADRS-S)
Change in MADRS-S at post-treatment and follow-ups compared to baseline
Time frame: baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Beck Anxiety Inventory (BAI)
Change in BAI at post-treatment and follow-ups compared to baseline
Time frame: baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Anxiety Sensitivity Index (ASI)
Change in ASI at post-treatment and follow-ups compared to baseline
Time frame: baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Sheehan Disability Scale (SDS)
Change in SDS at post-treatment and follow-ups compared to baseline
Time frame: baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Trimbos and institute of medical technology assessment cost questionnaire (TIC-P)
Change in TIC-P at post-treatment and follow-ups compared to baseline
Time frame: baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Euroqol-5D (EQ-5D)
Change in EQ-5D at post-treatment and follow-ups compared to baseline
Time frame: baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Insomnia Severity Index (ISI)
Change in ISI at post-treatment and follow-ups compared to baseline
Time frame: baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Self-rated health 5 (SRH-5)
Change in SRH-5 at post-treatment and follow-ups compared to baseline
Time frame: baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Quality of Life Inventory (QOLI)
Change in QOLI at post-treatment and follow-ups compared to baseline
Time frame: baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Alcohol Use Disorders Identification Test (AUDIT)
Change in AUDIT at post-treatment and follow-ups compared to baseline
Time frame: baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Client Satisfaction Questionnaire (CSQ-8)
For assessing satisfaction with treatment
Time frame: Post-treatment (12 weeks)
Sickness Questionnaire (SQ)
Change in SQ at post-treatment and follow-ups compared to baseline
Time frame: baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Perceived Vulnerability for Disease (PVD)
Change in PVD at post-treatment and follow-ups compared to baseline
Time frame: baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
Disgust Scale-Rev (DS-R)
Change in DS-R at post-treatment and follow-ups compared to baseline
Time frame: baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
WHO Disability Assessment Schedule (WHODAS) 2.0, 12-item version
Change in WHODAS at post-treatment and follow-ups compared to baseline
Time frame: baseline, post-treatment (12 weeks), 6 month follow-up, 12 month follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.